Febuxostat

규격

144060-53-7CAS 번호

682-158-6EC 번호

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acidIUPAC 명칭

C16H16N2O3S화학식

316.4 g/mol분자량

Febuxostat; 144060-53-7; Adenuric; Uloric; TMX-67; Tei 6720; Tei-6720; TMX 67; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid; Zurig; Febuxostatum; DTXSID8048650; NSC-758874; 101V0R1N2E; 5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-; DTXCID1028576; CHEBI:31596; 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid; 2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID; 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid; TEI6720; 6720, TEI; RefChem:57913; Febuxostat tablets 40 mg; Febuxostat tablets 80 mg; M04AA03; 682-158-6; 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid; Feburic; MFCD00871598; Febuxostat (Uloric); 2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID; CHEMBL1164729; Febuxostat [USAN]; NCGC00182059-02; 2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid; SMR002529566; Uloric (TN); CAS-144060-53-7; 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid; Donifoxate; Febuday; Goturic; Febric; Goutex; Febuxostat [USAN:INN:BAN]; UNII-101V0R1N2E; Adenuric;; Goturic;; Uloric;; Feburic (TN); Febuxostat (Standard); FEBUXOSTAT?; 111GE013; FEBUXOSTAT [MI]; FEBUXOSTAT [INN]; FEBUXOSTAT [JAN]; S1547; FEBUXOSTAT [VANDF]; 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid; FEBUXOSTAT [MART.]; FEBUXOSTAT [WHO-DD]; Febuxostat,Uloric, TMX-67; MLS004774136; MLS006011568; FEBUXOSTAT [EMA EPAR]; SCHEMBL249339; Febuxostat - Bio-X trade mark; GTPL6817; orb1310305; orb3141276; Febuxostat (JP18/USAN/INN); FEBUXOSTAT [ORANGE BOOK]; Febuxostat, >=98% (HPLC); SCHEMBL29398803; GLXC-05201; HMS3264C20; HMS3655C03; HMS3673M21; HMS3743I09; HMS3868J03; HMS5079I14; MX-67; Pharmakon1600-01504286; KBC53974; MSK10866; Tox21_113004; AC-425; BBL036503; BDBM50320491; EBC-08698; FD7322; HY-14268R; NSC758874; STL559020; AKOS015841695; Tox21_113004_1; BS-1018; CCG-213303; CS-0403; DB04854; FC10814; NSC 758874; PB33929; NCGC00182059-03; NCGC00182059-08; BC164443; HY-14268; SY053100; F0847; F1607; NS00004138; SW219283-1; D01206; EN300-122360; SBI-0653454.0001; AB01274796-01; AB01274796_02; AB01274796_03; F213321; Q417296; SR-01000940023; SR-01000940023-2; BRD-K48367671-001-01-8; BRD-K48367671-001-05-9; BRD-K48367671-001-06-7; Z1541759499; 2-(3-cyano-4-isobutyloxy)-phenyl-4-methyl-5-thiazolecarboxylic acid; 2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid; 2-[3-Cyano-4-(2-methylpropoxyphenyl]-4-methyl-5-thiazolecarboxylic Acid-d7동의어